PL1648904T3 - Związki N-sulfonyloheterocyklopirolioalkiloaminowe jako ligandy 5-hydroksytryptaminy-6 - Google Patents
Związki N-sulfonyloheterocyklopirolioalkiloaminowe jako ligandy 5-hydroksytryptaminy-6Info
- Publication number
- PL1648904T3 PL1648904T3 PL04757294T PL04757294T PL1648904T3 PL 1648904 T3 PL1648904 T3 PL 1648904T3 PL 04757294 T PL04757294 T PL 04757294T PL 04757294 T PL04757294 T PL 04757294T PL 1648904 T3 PL1648904 T3 PL 1648904T3
- Authority
- PL
- Poland
- Prior art keywords
- sulfonylheterocyclopyrrolylalkylamine
- hydroxytryptamine
- ligands
- compounds
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49162203P | 2003-07-31 | 2003-07-31 | |
| EP04757294A EP1648904B1 (en) | 2003-07-31 | 2004-07-23 | N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands |
| PCT/US2004/023993 WO2005012311A1 (en) | 2003-07-31 | 2004-07-23 | N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1648904T3 true PL1648904T3 (pl) | 2008-01-31 |
Family
ID=34115532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04757294T PL1648904T3 (pl) | 2003-07-31 | 2004-07-23 | Związki N-sulfonyloheterocyklopirolioalkiloaminowe jako ligandy 5-hydroksytryptaminy-6 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7041695B2 (pl) |
| EP (1) | EP1648904B1 (pl) |
| JP (1) | JP2007500701A (pl) |
| CN (1) | CN100443487C (pl) |
| AT (1) | ATE370955T1 (pl) |
| AU (1) | AU2004261606A1 (pl) |
| BR (1) | BRPI0413158A (pl) |
| CA (1) | CA2532382A1 (pl) |
| DE (1) | DE602004008474T2 (pl) |
| DK (1) | DK1648904T3 (pl) |
| ES (1) | ES2290740T3 (pl) |
| MX (1) | MXPA06000957A (pl) |
| PL (1) | PL1648904T3 (pl) |
| WO (1) | WO2005012311A1 (pl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2290740T3 (es) * | 2003-07-31 | 2008-02-16 | Wyeth | Compuestos de n-sulfonilheterociclopirrolilalquilamina como ligandos de 5-hidroxitriptamina-6. |
| GB0403781D0 (en) * | 2004-02-20 | 2004-03-24 | Astrazeneca Ab | Chemical compounds |
| US7314875B2 (en) * | 2004-04-13 | 2008-01-01 | Cephalon, Inc. | Tricyclic aromatic and bis-phenyl sulfinyl derivatives |
| TW200800959A (en) * | 2005-06-10 | 2008-01-01 | Wyeth Corp | Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor |
| CA2612109A1 (en) * | 2005-06-17 | 2006-12-28 | Wyeth | Tricyclic compounds useful as serotonin inhibitors and 5-ht1a agonists and antagonists |
| TW200808741A (en) * | 2006-06-09 | 2008-02-16 | Wyeth Corp | 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts |
| TW200808740A (en) * | 2006-06-09 | 2008-02-16 | Wyeth Corp | Succinate salts of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline and crystalline forms thereof |
| TW200811144A (en) * | 2006-06-09 | 2008-03-01 | Wyeth Corp | Crystalline forms of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline |
| US20080262228A1 (en) * | 2006-11-28 | 2008-10-23 | Wyeth | Metabolites of 5-fluoro-8- quinoline and methods of preparation and uses thereof |
| TW200901974A (en) | 2007-01-16 | 2009-01-16 | Wyeth Corp | Compounds, compositions, and methods of making and using them |
| EP2053052A1 (en) | 2007-10-23 | 2009-04-29 | Laboratorios del Dr. Esteve S.A. | Process for the preparation of 6-substituted imidazo[2,1-b]thiazole-5-sulfonyl halide |
| EP3563842A1 (en) | 2009-04-29 | 2019-11-06 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
| EP3615540B1 (de) | 2017-04-24 | 2022-04-27 | Bayer Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2537974A1 (fr) * | 1982-12-16 | 1984-06-22 | Adir | Nouveaux derives de thieno (2,3-b) pyrrole, leur procede de preparation et les compositions pharmaceutiques les renfermant |
| GB9820113D0 (en) * | 1998-09-15 | 1998-11-11 | Merck Sharp & Dohme | Therapeutic agents |
| DK1149078T3 (da) * | 1998-12-11 | 2006-07-10 | Univ Virginia Commonwealth | Selektive 5-HT6-receptorligander |
| GB0016454D0 (en) | 2000-07-04 | 2000-08-23 | Hoffmann La Roche | Thienopyrrolidinones |
| DE10063992A1 (de) | 2000-12-21 | 2002-07-04 | Max Planck Gesellschaft | Tryptophan-Analoga in Proteinen, Peptiden und peptidischen Leitstrukturen |
| PL363238A1 (pl) * | 2000-12-22 | 2004-11-15 | Wyeth | Związki heterocykliloalkilo-indolowe i-azaindolowe jako ligandy receptora 5-hydroksytryptaminowego-6 |
| US6730694B1 (en) | 2001-07-20 | 2004-05-04 | Eli Lilly And Company | sPLA2 inhibitors |
| ES2269827T3 (es) * | 2001-12-20 | 2007-04-01 | Wyeth | Derivados de indolilalquilamina como ligandos de 5-hidroxitriptamina-6. |
| TW200407127A (en) | 2002-08-21 | 2004-05-16 | Astrazeneca Ab | Chemical compounds |
| US7317010B2 (en) * | 2002-08-21 | 2008-01-08 | Astrazeneca Ab | Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone |
| ES2290740T3 (es) * | 2003-07-31 | 2008-02-16 | Wyeth | Compuestos de n-sulfonilheterociclopirrolilalquilamina como ligandos de 5-hidroxitriptamina-6. |
-
2004
- 2004-07-23 ES ES04757294T patent/ES2290740T3/es active Active
- 2004-07-23 AT AT04757294T patent/ATE370955T1/de not_active IP Right Cessation
- 2004-07-23 CN CNB2004800210108A patent/CN100443487C/zh not_active Expired - Fee Related
- 2004-07-23 DE DE602004008474T patent/DE602004008474T2/de not_active Expired - Fee Related
- 2004-07-23 PL PL04757294T patent/PL1648904T3/pl unknown
- 2004-07-23 WO PCT/US2004/023993 patent/WO2005012311A1/en active IP Right Grant
- 2004-07-23 BR BRPI0413158-4A patent/BRPI0413158A/pt not_active IP Right Cessation
- 2004-07-23 MX MXPA06000957A patent/MXPA06000957A/es active IP Right Grant
- 2004-07-23 DK DK04757294T patent/DK1648904T3/da active
- 2004-07-23 AU AU2004261606A patent/AU2004261606A1/en not_active Withdrawn
- 2004-07-23 CA CA002532382A patent/CA2532382A1/en not_active Abandoned
- 2004-07-23 JP JP2006521964A patent/JP2007500701A/ja not_active Withdrawn
- 2004-07-23 EP EP04757294A patent/EP1648904B1/en active Active
- 2004-07-30 US US10/909,092 patent/US7041695B2/en not_active Expired - Fee Related
-
2006
- 2006-02-01 US US11/344,765 patent/US7220756B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20050038088A1 (en) | 2005-02-17 |
| WO2005012311A1 (en) | 2005-02-10 |
| EP1648904A1 (en) | 2006-04-26 |
| AU2004261606A1 (en) | 2005-02-10 |
| JP2007500701A (ja) | 2007-01-18 |
| DK1648904T3 (da) | 2007-10-22 |
| DE602004008474T2 (de) | 2008-05-15 |
| ES2290740T3 (es) | 2008-02-16 |
| ATE370955T1 (de) | 2007-09-15 |
| US20060160878A1 (en) | 2006-07-20 |
| MXPA06000957A (es) | 2006-03-30 |
| US7220756B2 (en) | 2007-05-22 |
| US7041695B2 (en) | 2006-05-09 |
| CN1826346A (zh) | 2006-08-30 |
| CN100443487C (zh) | 2008-12-17 |
| CA2532382A1 (en) | 2005-02-10 |
| BRPI0413158A (pt) | 2006-10-03 |
| DE602004008474D1 (de) | 2007-10-04 |
| EP1648904B1 (en) | 2007-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA04005886A (es) | Derivados de azaindolilalquilamina como ligandos de 5-hidroxitirptamina-6. | |
| MXPA05008438A (es) | Heterociclil-3-sulfonilindazoles como ligandos de 5-hidroxitriptamina-6. | |
| CY1108738T1 (el) | Θεραπευτικοι παραγοντες χρησιμοι για την αγωγη του πονου | |
| NO20050014L (no) | 1-Heterosyklylalkyl-3-sulfonylindol eller -indazolderivater som 5-hydroksytryptamin-6 ligander | |
| NO20050007L (no) | 1-Heterosyklylalkyl-3-sulfonylazaindol eller -azaindazolderivater som 5-hydroksytryptamin-6 ligander | |
| SE0201635D0 (sv) | Novel compounds | |
| MXPA04003087A (es) | Derivados de cromano como ligados de 5-hidroxitriptamina-6. | |
| MXPA06000701A (es) | Compuestos de sulfonildihidrobencimidazolona como ligandos de 5-hidroxitriptamina-6. | |
| WO2002051837A3 (en) | Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands | |
| SE0303180D0 (sv) | Novel compounds | |
| SE0302232D0 (sv) | Novel Compounds | |
| BR0206633A (pt) | Derivados de 1-aril- ou 1-arilsulfonilbenzazol como ligandos de 5-hidroxitriptamina-6 | |
| GEP20125437B (en) | New sulfonamide derivatives as bradykinin antagonists | |
| DE602005016929D1 (de) | Liganden für den cannabinoidrezeptoren | |
| HK1094425A1 (en) | Substituted 2-aminotetralines for the preventive treatment of parkinson's disease | |
| TW200510334A (en) | Preraration and use of aryl alkyl acid derivatives for the treatment of obesity | |
| WO2007142905A3 (en) | 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands | |
| WO2002051832A3 (en) | Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands | |
| PL1648904T3 (pl) | Związki N-sulfonyloheterocyklopirolioalkiloaminowe jako ligandy 5-hydroksytryptaminy-6 | |
| UA101602C2 (ru) | Производные бензамидов как антагонисты брадикининовых рецепторов | |
| WO2002085853A3 (en) | Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands | |
| UA94053C2 (ru) | Замещенные производные 3-сульфонилиндазола в качестве лигандов гидрокситриптамина-6 | |
| MX2008002158A (es) | Derivados de azinil-3-sulfonilindazol como ligandos de 5-hidroxitriptamina-6. | |
| DE60220385D1 (de) | Benzimidazole zur behandlung sexueller fehlfunktionen | |
| MY158069A (en) | Tricyclic compound and pharmaceutical use thereof |